Work

Exploring the relationship between serum magnesium levels, genetic variants, and chronic kidney disease: a prospective study

Year: 2025

Type: article

Abstract: Background: Recent evidence suggests that magnesium deficiency may play a role in the development and progression of chronic kidney disease (CKD). We assessed the association between genetic variations, serum magnesium levels and CKD risk in the general population. Methods: = 4047; mean age 53 years; 54% female; mean follow-up 12.5 years), Cox regression models evaluated the effects of hypomagnesemia on CKD risk. Genetic risk scores and mediation analyses were used to assess the direct and indirect effects of single-nucleotide polymorphisms (SNPs) on CKD development through magnesium levels. One-sample and two-sample Mendelian randomization (MR) analyses were conducted to examine the causal relationship between genetically predicted serum magnesium levels and CKD risk. Results: = .010). Analyses based on single SNPs and SNP scores did not reveal direct effects on CKD risk. Mediation analyses demonstrated that four SNPs exerted significant indirect effects on CKD risk through serum magnesium levels. However, the proportion of the total effect mediated by magnesium was low and not statistically significant. MR analyses did not provide strong evidence for a significant causal relationship between genetically predicted magnesium levels and CKD risk. Conclusions: Hypomagnesemia was significantly associated with an increased risk of long-term CKD. Genetic analysis suggests that serum magnesium levels may play an indirect role in CKD risk, but no clear causal relationship was found.

Source: Clinical Kidney Journal

DOI: 10.1093/ckj/sfaf254

Authors: Sisi Xie, Idris Guessous, Dela Golshayan, Aurélien Thomas, Julien Vaucher, Pedro Marques-Vidal